|
May 10
|
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
|
|
May 10
|
Catalyst's New CEO Has Big Ideas For The Small Biotech
|
|
May 8
|
Update: AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents
|
|
May 8
|
Every household should be forced to have a smart meter, says British Gas boss
|
|
May 8
|
AstraZeneca withdraws Covid-19 vaccine, citing low demand
|
|
May 8
|
Ionis (IONS) Q1 Loss Narrower Than Expected, Sales Miss
|
|
May 8
|
AstraZeneca withdraws COVID-19 vaccine, citing declining demand
|
|
May 8
|
AstraZeneca pulls its COVID-19 vaccine from the European market
|
|
May 8
|
AstraZeneca to withdraw Covid-19 vaccine globally
|
|
May 8
|
Q1 2024 Ionis Pharmaceuticals Inc Earnings Call
|
|
Jan 15
|
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and AstraZeneca
|
|
Jan 12
|
Astrazeneca (AZN) Laps the Stock Market: Here's Why
|
|
Jan 12
|
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
|
|
Jan 11
|
Here's Why Astrazeneca (AZN) Fell More Than Broader Market
|
|
Jan 10
|
JPM's annual healthcare conference: Here's what's next for GLP-1s and the weight loss market
|
|
Jan 2
|
China Approves AstraZeneca-Sanofi's Respiratory Syncytial Virus Drug To Prevent Infection In Infants
|
|
Jan 2
|
Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca
|
|
Dec 29
|
Biotech Stocks Were Tanking. The Cure? M&A.
|
|
Dec 29
|
Astrazeneca (AZN) Ascends While Market Falls: Some Facts to Note
|
|
Dec 29
|
2023 Will Go Down As The Year Pharma Showed Its Determination To Beat Cancer
|